StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a report issued on Monday. The firm issued a hold rating on the software maker’s stock.
Veradigm Trading Down 1.7 %
MDRX opened at $10.40 on Monday. Veradigm has a one year low of $5.01 and a one year high of $12.66. The business’s 50-day simple moving average is $9.76 and its 200-day simple moving average is $9.50.
Institutional Trading of Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC purchased a new position in shares of Veradigm Inc. (NASDAQ:MDRX – Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
- Five stocks we like better than Veradigm
- 3 Healthcare Dividend Stocks to Buy
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- When to Sell a Stock for Profit or Loss
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
